{
    "Trade/Device Name(s)": [
        "PROFILE\u00ae-V MEDTOXScan\u00ae Drugs of Abuse Test System",
        "MEDTOXScan\u00ae Reader",
        "PROFILE\u00ae-V MEDTOXScan\u00ae Test Devices"
    ],
    "Submitter Information": "Medtox Diagnostics, Inc.",
    "510(k) Number": "K100023",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091454",
        "K992111"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JJQ",
        "DKZ",
        "DIS",
        "JXM",
        "DIO",
        "DJR",
        "DJC",
        "DJG",
        "LCM",
        "JXN",
        "LDJ",
        "LFG"
    ],
    "Summary Letter Date": "December 31, 2009",
    "Summary Letter Received Date": "January 5, 2010",
    "Submission Date": "November 10, 2009",
    "Regulation Number(s)": [
        "21CFR862.2300",
        "21CFR862.3100",
        "21CFR862.3150",
        "21CFR862.3170",
        "21CFR862.3250",
        "21CFR862.3620",
        "21CFR862.3610",
        "21CFR862.3650",
        "21CFR862.3700",
        "21CFR862.3870",
        "21CFR862.3910"
    ],
    "Regulation Name(s)": [
        "Colorimeter, Photometer, Spectrophotometer for Clinical Use",
        "Amphetamine Test System",
        "Barbiturate Test System",
        "Benzodiazepine Test System",
        "Cocaine and cocaine metabolite Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Opiate Test System",
        "Propoxyphene Test System",
        "Cannabinoid Test System",
        "Tricyclic Anti-depressant Drugs Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines (d-Amphetamine)",
        "Barbiturates (Butalbital)",
        "Benzodiazepines (Nordiazepam)",
        "Buprenorphine (Buprenorphine)",
        "Cocaine (Benzoylecgonine)",
        "Methadone (Methadone)",
        "Methamphetamine (d-Methamphetamine)",
        "Opiates (Morphine)",
        "Oxycodone (Oxycodone)",
        "Phencyclidine (Phencyclidine)",
        "Propoxyphene (Norpropoxyphene)",
        "THC (Cannabinoids, 11-nor-9-carboxy-\u03949-THC)",
        "Tricyclic Antidepressants (Desipramine)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MEDTOXScan\u00ae Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic lateral flow",
        "Contact imaging sensor (CIS)",
        "Instrumented qualitative detection"
    ],
    "Methodologies": [
        "Immunochromatographic testing",
        "Instrument-based interpretation"
    ],
    "Submission Type(s)": [
        "Test",
        "Instrument",
        "System",
        "Cassette",
        "Reader",
        "Reagent",
        "Quality control material",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for PROFILE\u00ae-V MEDTOXScan\u00ae Drugs of Abuse Test System for rapid, qualitative detection of multiple drug classes in human urine using instrumented immunochromatographic assay.",
    "Indications for Use Summary": "Rapid, qualitative detection of amphetamines, barbiturates, benzodiazepines, buprenorphine, cocaine, methadone, methamphetamine, opiates, oxycodone, phencyclidine, propoxyphene, THC (cannabinoids), and tricyclic antidepressants or their metabolites in human urine; for in vitro diagnostic and professional use only, not for point-of-care; requires instrumented interpretation.",
    "fda_folder": "Toxicology"
}